Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 1/2017

Open Access 01-12-2017 | Letter

Antiarrhythmic drugs in out-of-hospital cardiac arrest: is there a place for potassium chloride?

Authors: Romain Jouffroy, Benoît Vivien

Published in: Critical Care | Issue 1/2017

Login to get access

Excerpt

In the March 2017 issue of Critical Care, Tagami et al. [1] emphasized that amiodarone, lidocaine, and nifekalant similarly improve survival at hospital admission for out-of-hospital cardiac arrest (OHCA) patients due to refractory ventricular fibrillation (VF). However, neither amiodarone nor lidocaine has been shown to improve long-term survival or neurologic recovery [2]. …
Literature
1.
Tagami T, Yasunaga H, Yokota H. Antiarrhythmic drugs for out-of-hospital cardiac arrest with refractory ventricular fibrillation. Crit Care. 2017;21(1):59.CrossRefPubMedPubMedCentral
2.
Kudenchuk PJ, Brown SP, Daya M, et al. Amiodarone, lidocaine, or placebo in out-of-hospital cardiac arrest. N Engl J Med. 2016;374(18):1711–22.CrossRefPubMed
3.
Soar J, Nolan JP, Bottiger BW, et al. European Resuscitation Council Guidelines for Resuscitation 2015: Section 3. Adult advanced life support. Resuscitation. 2015;95:100–47.CrossRefPubMed
4.
Beyersdorf F, Kirsch M, Buckberg GD, Allen BS. Warm glutamate/aspartate enriched blood cardioplegic solution for perioperative sudden death. J Thorac Cardiovasc Surg. 1992;104(4):1141–7.PubMed
5.
Jouffroy R, Lamhaut L, Philippe P, An K, Carli P, Vivien B. A new approach for treatment of refractory ventricular fibrillation allowed by extra corporeal lifesupport (ECLS)? Resuscitation. 2014;85(8):e118.CrossRefPubMed
Metadata
Title
Antiarrhythmic drugs in out-of-hospital cardiac arrest: is there a place for potassium chloride?
Authors
Romain Jouffroy
Benoît Vivien
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2017
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-017-1732-z

Other articles of this Issue 1/2017

Critical Care 1/2017 Go to the issue

Research

Early psychological screening of intensive care unit survivors: a prospective cohort study

Research

Whole-body vibration to prevent intensive care unit-acquired weakness: safety, feasibility, and metabolic response

Research

Evidence of altered haemostasis in an ovine model of venovenous extracorporeal membrane oxygenation support

Research

Translational evidence for two distinct patterns of neuroaxonal injury in sepsis: a longitudinal, prospective translational study

Review

The future of mechanical ventilation: lessons from the present and the past

Editorial

Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections